{"id":142445,"date":"2019-02-26T05:03:18","date_gmt":"2019-02-26T10:03:18","guid":{"rendered":"https:\/\/www.countingpips.com\/?p=142445"},"modified":"2019-02-25T07:03:42","modified_gmt":"2019-02-25T12:03:42","slug":"livestock-feed-developer-partners-to-initiate-product-sales-in-the-u-s","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/forex\/2019\/02\/livestock-feed-developer-partners-to-initiate-product-sales-in-the-u-s\/","title":{"rendered":"Livestock Feed Developer Partners to Initiate Product Sales in the U.S."},"content":{"rendered":"
February 26, 2019<\/div>
\r\n<\/div><\/div>

By The Life Science Report<\/b><\/p>\n

Source: Streetwise Reports<\/em> \u00a0\u00a002\/22\/2019<\/a><\/b><\/p>\n

The arrangement represents this Canadian life sciences firm’s entr\u00e9e into a significant market.<\/p><\/blockquote>\n

Avivagen Inc. (VIV:TSX.V)<\/a> announced in a news release<\/a> it signed a partnership agreement with CSA Animal Nutrition for it to sell and distribute Avivagen’s OxC-beta livestock feed in the United States. CSA also will “coordinate commercial-scale validation research with potential customers.”<\/p>\n

“OxC-beta\u0099 Livestock is a proprietary product shown to be effective and economic in replacing the antibiotics commonly added to livestock feeds,” the company noted.<\/p>\n

Based in Ohio, CSA provides nutrition solutions and services for meat, milk and egg producers, feed manufacturers and nutrition consultants. With more than 20 years’ experience, the company has numerous relationships in the United States.<\/p>\n

The partnership with CSA gives Avivagen access to 20% of the global feed market for poultry, swine and dairy cattle, the release noted.<\/p>

\r\n
\r\n

Free Reports:<\/p><\/div>\r\n

\r\n

<\/a>\r\n\t Get Our Free Metatrader 4 Indicators<\/u><\/b><\/a> - Put Our Free MetaTrader 4 Custom Indicators on your charts when you join our Weekly Newsletter<\/p>

\r\n
\r\n
\r\n

<\/a>\r\n\t Get our Weekly Commitment of Traders Reports<\/u><\/b><\/a> - See where the biggest traders (Hedge Funds and Commercial Hedgers) are positioned in the futures markets on a weekly basis.<\/p>

\r\n<\/div>\r\n

\r\n
<\/div>\n

“We’re very excited to be entering into this important relationship that will bring OxC-beta to this crucial market and allow for the sale of OxC-beta within the United States,” said Kym Anthony, chairman and interim CEO of Avivagen. “With their extensive technical experience and relationships and ability to access the US livestock and poultry markets, CSA represents a strong partner for Avivagen. The timing is good given the regulatory process in the US is now completed and we look to add sales and distribution networks in new markets to significantly drive our sales.”<\/p>\n

According to Avivagen, “As an independent firm, CSA has the flexibility and expertise to reach a variety of customers across numerous species, from integrated commercial livestock and poultry production companies and young animal product manufacturers to premix blenders, thereby enhancing the potential adoption and sale of OxC-beta.”<\/p>\n

\n

Read what other experts are saying about:<\/p>\n